These findings — from a blood test to improvements in drug delivery — may lead to better diagnosis and treatment of the ...

Even after surgery and chemotherapy, some cancers, like pancreatic and colorectal, maintain a foothold in the body and ...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced that on Monday, Jan. 26, 2026, at 8:30 am Eastern Time, the Company will host a webcast and ...

U.S. Biological Buffers Market was Valued at USD 0.38 Billion in 2025 and is Expected to Reach USD 0.70 billion by 2033 Due to Rising Biologics and Vaccine DevelopmentAustin, Jan. 20, 2026 (GLOBE ...

Key market opportunities in the RNA Therapy Clinical Trials sector include an increase in chronic and rare diseases, advancements in delivery technologies like lipid nanoparticles, robust venture ...

Michael Kalos, Ph.D., is the founder and managing director of Next Pillar Consulting, where he advises biopharmaceutical and venture organizations. He is also a Venture Partner with Alloy Therapeutics ...

BEIJING, Jan. 20, 2026 /PRNewswire/ -- Beijing Tsingke Biotech Co., Ltd., a leading biotechnology company, today announced ...

UPSIDE Foods is building "a new vertical business in the life sciences industry with an initial focus on cell culture media.” ...

Beijing Tsingke Biotech Co., Ltd., a leading biotechnology company, today announced the launch of its redesigned global ...

Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.

DOVER, DE, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The safety of parenteral medicines and medical devices ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced the appointment of two additional key scientific ...